OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
68 hedge funds and large institutions have $89.2M invested in OptiNose in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 13 closing their positions.
1% more funds holding
Funds holding: 67 → 68 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0.88% less ownership
Funds ownership: 3.98% → 3.09% (-0.88%)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
30% less capital invested
Capital invested by funds: $128M → $89.2M (-$38.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.82M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.59M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.29M |
| 4 |
Renaissance Technologies
New York
|
+$936K |
| 5 |
SCM
Snow Capital Management
Sewickley,
Pennsylvania
|
+$587K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$11.4M |
| 2 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$8.18M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$7.29M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$2.48M |
| 5 |
ACM
Altium Capital Management
New York
|
-$1.9M |
OPTN Hedge Fund Activity: Q1 2021 in Review
68 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2021, worth a combined $89.2M — down 30% from $128M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new OPTN positions and 13 closed out — a net gain of 1 holder — while 18 added to existing stakes and 23 trimmed.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $1.82M. The largest seller was GMT Capital, cutting an estimated $11.4M.
- 68 institutional investors held OptiNose (OPTN) as of Q1 2021, up from 67 in Q4 2020.
- Funds reported $89.2M of OptiNose stock for Q1 2021, down 30% quarter-over-quarter.
- 14 funds opened new OptiNose positions in Q1 2021 and 13 closed out, a net change of +1 holder.
- The largest OptiNose buyer in Q1 2021 was Jacobs Levy Equity Management, an estimated $1.82M added.
- The largest OptiNose seller in Q1 2021 was GMT Capital, an estimated $11.4M sold.
Based on aggregated 13F filings for Q1 2021.